Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 11-2012 | 09-2012 | 08-2012 | 06-2012 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -4 | 0 | N/A | 0 |
| Operating Cash Flow | $-4 | $0 | $N/A | $0 |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $N/A | $0 | $N/A | $0 |
| Cash Flows From Financing Activities | ||||
| Financing Cash Flow | $N/A | $0 | $N/A | $0 |
| Beginning Cash Position | 5 | 0 | N/A | 0 |
| End Cash Position | 1 | 0 | N/A | 0 |
| Net Cash Flow | $-4 | $0 | $N/A | $0 |
| Free Cash Flow | ||||
| Operating Cash Flow | -4 | 0 | N/A | 0 |
| Free Cash Flow | -4 | 0 | 0 | 0 |